Bioclub announced that it has received investment in a round of funding from new investor Hangzhou Tigermed Consulting Co., Ltd on August 7, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.69 CNY | -0.10% | +0.98% | +8.59% |
Apr. 25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
Apr. 25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.59% | 6.7B | |
+17.96% | 47.02B | |
+48.77% | 41.86B | |
+0.80% | 41.76B | |
-4.27% | 28.8B | |
+11.83% | 26.05B | |
-21.17% | 19.15B | |
+4.32% | 12.55B | |
+28.51% | 12.34B | |
-4.46% | 11.82B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- Bioclub announced that it has received funding from Hangzhou Tigermed Consulting Co., Ltd